Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Price:
38.66
USD
-1.98%
Market Closed
Market Cap:
$4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
|
US |
|
Timah Tbk PT
IDX:TINS
|
ID |
|
Huron Consulting Group Inc
NASDAQ:HURN
|
US |
|
Shizuoka Gas Co Ltd
TSE:9543
|
JP |
|
OEM International AB
STO:OEM B
|
SE |
|
Apollo Tricoat Tubes Ltd
BSE:538566
|
IN |
|
Santec Corp
TSE:6777
|
JP |
|
N
|
Neste Oyj
XETRA:NEF
|
FI |
|
Alight Inc
NYSE:ALIT
|
US |
|
Titan Company Ltd
NSE:TITAN
|
IN |
|
Fractale Corp
TSE:3750
|
JP |
|
J
|
JD Sports Fashion PLC
OTC:JDDSF
|
UK |
|
Rare Element Resources Ltd
OTC:REEMF
|
US |
|
A
|
AWC Bhd
KLSE:AWC
|
MY |
|
Garo AB
STO:GARO
|
SE |
|
Coconala Inc
TSE:4176
|
JP |
|
Carillion PLC
LSE:CLLN
|
UK |
|
C
|
Celestica Inc
NYSE:CLS
|
CA |
|
G
|
Getin Holding SA
WSE:GTN
|
PL |
|
S
|
Sun Life Financial Inc
NYSE:SLF
|
CA |
|
N
|
Nueva Expresion Textil SA
LSE:0R6G
|
ES |
|
S
|
Smurfit Kappa Group PLC
LSE:SKG
|
IE |
|
Societe Industrielle et Financiere de l'Artois SA
PAR:ARTO
|
FR |
|
Nissin Foods Co Ltd
HKEX:1475
|
HK |
Balance Sheet
Balance Sheet Decomposition
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Balance Sheet
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
12
|
14
|
45
|
40
|
93
|
201
|
33
|
55
|
265
|
102
|
|
| Cash Equivalents |
12
|
14
|
45
|
40
|
93
|
201
|
33
|
55
|
265
|
102
|
|
| Short-Term Investments |
0
|
0
|
119
|
78
|
78
|
133
|
302
|
504
|
1 090
|
926
|
|
| Total Receivables |
0
|
1
|
2
|
1
|
2
|
2
|
2
|
9
|
8
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Current Assets |
0
|
0
|
1
|
4
|
5
|
10
|
9
|
7
|
13
|
18
|
|
| Total Current Assets |
12
|
15
|
167
|
123
|
178
|
345
|
345
|
574
|
1 375
|
1 048
|
|
| PP&E Net |
0
|
0
|
4
|
7
|
5
|
5
|
5
|
57
|
56
|
55
|
|
| PP&E Gross |
0
|
0
|
4
|
7
|
5
|
5
|
5
|
57
|
56
|
55
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
3
|
4
|
4
|
5
|
8
|
8
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
23
|
|
| Total Assets |
13
N/A
|
16
+24%
|
171
+999%
|
130
-24%
|
183
+41%
|
351
+91%
|
352
+0%
|
635
+80%
|
1 435
+126%
|
1 126
-21%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
2
|
5
|
6
|
9
|
7
|
7
|
6
|
23
|
|
| Accrued Liabilities |
1
|
1
|
7
|
4
|
5
|
8
|
19
|
35
|
52
|
61
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
|
| Total Current Liabilities |
1
|
1
|
8
|
8
|
11
|
16
|
28
|
44
|
60
|
85
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
3
|
5
|
4
|
3
|
8
|
52
|
50
|
49
|
|
| Total Liabilities |
1
N/A
|
1
-18%
|
11
+1 144%
|
13
+18%
|
15
+10%
|
19
+32%
|
36
+87%
|
96
+169%
|
110
+14%
|
134
+22%
|
|
| Equity | |||||||||||
| Common Stock |
18
|
30
|
0
|
211
|
337
|
608
|
759
|
1 192
|
2 276
|
2 408
|
|
| Retained Earnings |
7
|
16
|
43
|
94
|
168
|
275
|
439
|
654
|
952
|
1 417
|
|
| Additional Paid In Capital |
1
|
1
|
204
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
1
|
1
|
2
|
|
| Total Equity |
12
N/A
|
15
+28%
|
160
+990%
|
117
-27%
|
169
+44%
|
332
+97%
|
316
-5%
|
539
+70%
|
1 325
+146%
|
992
-25%
|
|
| Total Liabilities & Equity |
13
N/A
|
16
+24%
|
171
+999%
|
130
-24%
|
183
+41%
|
351
+91%
|
352
+0%
|
635
+80%
|
1 435
+126%
|
1 126
-21%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
22
|
22
|
24
|
24
|
33
|
48
|
54
|
68
|
93
|
96
|
|
Switch to:
Switch to:
See Also
Discover More
